Australians are preparing for significant numbers of respiratory infections this winter, as cases of influenza, RSV, and ...

After decades of fits and starts, scientists finally got the world’s first vaccines against respiratory syncytial virus ...

A recent study highlights the alarming increase in death risk associated with respiratory syncytial virus (RSV) among adults.

Adults diagnosed with RSV-associated acute respiratory infection face nearly triple the risk of death within 1 year compared ...

Common respiratory condition nearly triples the risk of death in adults, new study finds A major study presented today at ...

A study presented at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute ...

Acute respiratory syncytial virus was associated with elevated incidence of cardiovascular events among older adults, ...

The Ministry of Public Health (MoPH) has advised the public, especially the vulnerable to take the Respiratory Syncytial ...

Knowledge of respiratory syncytial virus (RSV) disease and RSV vaccine eligibility is low among hospitalized older adults, ...

(NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology ...

A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) face a 2.7-fold higher risk of death ...